loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Xylometazoline

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Xylometazoline

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 543Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    JGL’s team at the largest congress of the pharmaceutical industry
    JGL’s team at the largest congress of the pharmaceutical industry

    08 Dec 2019

    // PRESS RELEASE

    https://www.jgl.hr/en/jgls-team-at-the-largest-congress-of-the-pharmaceutical-industry

    PRESS RELEASE
    08 Dec 2019
    Share Share
    FDA approval of controversial drug for DMD raises concern and hope
    FDA approval of controversial drug for DMD raises concern and hope

    16 Nov 2016

    // NEWS MEDICAL NET

    http://www.news-medical.net/news/20161117/FDA-approval-of-controversial-drug-for-Duchenne-muscular-dystrophy-raises-concern-and-hope.aspx?

    NEWS MEDICAL NET
    16 Nov 2016
    Share Share
    GSK Healthcare shifts focus from Horlicks, banks on Sensodyne, Crocin
    GSK Healthcare shifts focus from Horlicks, banks on Sensodyne, Crocin

    05 Apr 2016

    // Ratna Bhushan ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/gsk-healthcare-shifts-focus-from-horlicks-banks-on-sensodyne-crocin-to-drive-growth-in-india/articleshow/51706616.cms

    Ratna Bhushan ECONOMIC TIMES
    05 Apr 2016
    Share Share